Featured Research

from universities, journals, and other organizations

New type of defibrillator for patients at risk for sudden cardiac death

Date:
April 28, 2014
Source:
Loyola University Health System
Summary:
A new device called a subcutaneous implantable cardioverter defibrillator (S-ICD) prevents sudden cardiac death with an electric shock. A conductor wire is implanted just under the skin, rather than going into the heart. In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart. In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart,

Subcutaneous implantable cardioverter defibrillator (S-ICD).
Credit: Boston Scientific

Loyola University Medical Center has begun offering patients a new type of implantable defibrillator that prevents sudden cardiac death with an electric shock to the heart.

Related Articles


The device is called a subcutaneous implantable cardioverter defibrillator (S-ICD). Unlike other implantable defibrillators, a conductor wire from the new device does not go into the heart. Rather, the wire (called a lead) is implanted over the heart, just under the skin. (Subcutaneous means under the skin.)

In carefully selected patients, a S-ICD can reduce the risk of bleeding, blood clots and bloodstream infections, compared with a defibrillator with leads that go into the heart, said Peter Santucci, MD, an associate professor in the Division of Cardiology and medical director of the Implant Device Program.

Loyola's first S-ICD patient is Stacey Tyranski, 36, of Huntley, Ill., who recently went into cardiac arrest at a health club, where she was taking a Zumba fitness class. An off-duty firefighter saved her life by administering CPR and an electric shock from an automated external defibrillator.

Tyranski was taken to a local hospital and then transferred to Loyola, where she was fitted with the new S-ICD.

"It makes me feel safe," she said.

Tyranski has a congenital heart condition called transposition of the great vessels. The two major vessels that carry blood away from the heart -- the aorta and the pulmonary artery -were switched (transposed). Tyranski had surgery to repair the defect when she was an infant. But the technique used at the time has increased her risk for irregular, life-threatening heartbeats called arrhythmias, said Joel Hardin, MD a specialist in congenital heart disease and an associate professor in Loyola's Division of Cardiology.

The Food and Drug Administration has approved the S-ICD, and the device is covered by Medicare. "It can protect patients from sudden cardiac death without putting leads into the heart," Santucci said.

In a standard defibrillator device known as a transvenous ICD, a primary lead is guided through a vein in the upper chest and into the right ventricle of the heart. But this was not possible in Tyranski's case, due to a completely obstructed vein that normally would allow a wire to enter the heart. She thus was a good candidate for a S-ICD.

While the battery of a transvenous ICD is implanted in the upper chest, the battery of a S-ICD is implanted on the side of the chest under the arm pit.

An implantable defibrillator is indicated for patients who have survived cardiac arrest or have risk factors for cardiac arrest, including significant cardiomyopathy, structural heart disease, heart failure and certain genetic heart rhythm abnormalities. An implantable defibrillator continually monitors the patient's heart rhythm. If the heart begins to beat dangerously fast or chaotically, the device restores normal rhythm with an electric shock.

In a significant percentage of patients, the lead of a defibrillator will need to be replaced after 10 or 20 years. Removing a lead from a transvenous ICD carries a small risk of perforating or tearing the heart wall. Removing a lead from a S-ICD carries a lower risk of serious complication, Santucci said. In a transvenous ICD, an infection from the lead going into the heart can be life-threatening. By contrast, if there is an infection from a lead of a subcutaneous ICD, the infection is unlikely to reach the bloodstream, Santucci said.

The S-ICD can be especially beneficial to patients who are at high risk for infections and for younger patients who likely will need to have leads replaced one or more times during their lifetimes.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "New type of defibrillator for patients at risk for sudden cardiac death." ScienceDaily. ScienceDaily, 28 April 2014. <www.sciencedaily.com/releases/2014/04/140428154840.htm>.
Loyola University Health System. (2014, April 28). New type of defibrillator for patients at risk for sudden cardiac death. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2014/04/140428154840.htm
Loyola University Health System. "New type of defibrillator for patients at risk for sudden cardiac death." ScienceDaily. www.sciencedaily.com/releases/2014/04/140428154840.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.S. Ebola Response Measures Demonstrated

U.S. Ebola Response Measures Demonstrated

AP (Oct. 31, 2014) Officials in the Washington area showed off Ebola response measures being taken at Dulles International Airport and the National Institutes of Health. (Oct. 31) Video provided by AP
Powered by NewsLook.com
Fauci Says Ebola Risk in US "essentially Zero"

Fauci Says Ebola Risk in US "essentially Zero"

AP (Oct. 30, 2014) NIAID Director Anthony Fauci said the risk of Ebola becoming an epidemic in the U.S. is essentially zero Thursday at the Washington Ideas Forum. He also said an Ebola vaccine will be tested in West Africa in the next few months. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Nurse Defies Ebola Quarantine With Bike Ride

Nurse Defies Ebola Quarantine With Bike Ride

AP (Oct. 30, 2014) A nurse who vowed to defy Maine's voluntary quarantine for health care workers who treated Ebola patients followed through on her promise Thursday, leaving her home for an hour-long bike ride. (Oct. 30) Video provided by AP
Powered by NewsLook.com
Pot-Infused Edibles Raise Concerns in Colorado

Pot-Infused Edibles Raise Concerns in Colorado

AFP (Oct. 30, 2014) Colorado may have legalized marijuana for recreational use, but the debate around the decision still continues, with a recent - failed - attempt to ban cannabis-infused edibles. Duration: 01:53 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins